Tocolysis use after PPROM not linked to neurodevelopmental outcomes
May 29th 2024A recent study investigated the effects of antenatal tocolysis on neurodevelopmental outcomes among children aged 5.5 years following preterm prelabor rupture of membranes, revealing no significant differences in outcomes.
Read More
Similar delivery times between misoprostol dosages among obese patients reported
May 29th 2024A recent study found that obese patients undergoing induction of labor experienced similar delivery times regardless of whether they received 50 μg or 25 μg of vaginal misoprostol, though multiparous patients showed faster delivery with the higher dosage.
Read More
Major adverse pregnancy outcomes linked to long-term risk of kidney disease
May 28th 2024A recent study highlighted the significant association between adverse pregnancy outcomes and an elevated long-term risk of chronic kidney disease, emphasizing the need for heightened awareness and monitoring.
Read More
Study finds youth with developmental disabilities less likely to access reproductive health care
May 22nd 2024A recent study reveals that adolescents with autism and other developmental disabilities have fewer visits to obstetrician-gynecologists and lower hormonal contraceptive use compared to their typically developing peers, highlighting a need for improved reproductive health services.
Read More
LNG-IUS vs. radiofrequency EA for HMB: Similar long-term reintervention risks reported
May 22nd 2024A recent study reveals similar overall reintervention risks between a 52-mg levonorgestrel-releasing intrauterine system and radiofrequency endometrial ablation for treating heavy menstrual bleeding.
Read More
Addressing racial and ethnic disparities in brachial plexus birth Injury
May 20th 2024Mary Claire B. Manske, MD, discusses her findings on the unexplained increased risk of brachial plexus birth injury among Black and Hispanic infants, highlighting the need for improved prenatal care and further research.
Read More
Navigating menopause care: Expert insights from ACOG 2024
May 19th 2024At ACOG 2024, Monica M. Christmas, MD, FACOG, and Stephanie Faubion, MD, emphasize the importance of combating disinformation in menopause care and provide clinicians with evidence-based strategies to manage symptoms effectively.
Read More
Empowering ob-gyns to address sexual health concerns
May 18th 2024At the 2024 ACOG Annual Clinical & Scientific Meeting, experts emphasized the importance of equipping ob-gyns with the knowledge and tools to address sexual health issues, including hyperactive sexual desire disorder, anorgasmia, and pelvic pain.
Read More
New data shows elinzanetant's efficacy in treating menopausal symptoms
May 18th 2024Phase 3 data presented by JoAnn Pinkerton, MD, reveals that elinzanetant significantly improves hot flash frequency, sleep, and overall menopause quality of life, offering a promising alternative to estrogen therapy.
Read More
Laparoscopic RFA linked to enhanced pregnancy outcomes in uterine fibroid patients
May 18th 2024A recent study presented at the 2024 ACOG Clinical and Scientific Meeting reveals that laparoscopic radiofrequency ablation significantly improves pregnancy outcomes for women with uterine leiomyomas.
Read More
Mastering misoprostol: Comprehensive uses across trimesters
May 17th 2024Leanne R. McCloskey, MD, and Weronika A. Armstrong, MD, xplore the multifaceted applications of misoprostol in obstetrics, covering protocols, safety, and the impact on birth equity from early pregnancy loss to labor induction at ACOG 2024.
Read More
Navigating vasomotor symptoms in breast cancer patients
May 17th 2024Michelle Jacobson, MD, MHSc, FRCSC, shares critical perspectives on managing vasomotor symptoms in breast cancer patients at the recent ACOG Annual Clinical & Scientific Meeting, emphasizing the importance of tailored approaches amidst evolving treatment options and patient risks.
Read More
OASIS-1 trial reports reduced VMS frequency and severity from elinzanetant
May 17th 2024A recent study showcased at the 2024 ACOG Annual Clinical & Scientific Meeting unveils elinzanetant's efficacy in alleviating vasomotor symptoms, sleep disturbances, and enhancing menopause-related quality of life in postmenopausal women.
Read More
PCOS and irregular cycles tied to cardiometabolic risks
May 15th 2024A comprehensive analysis reveals strong associations between polycystic ovary syndrome, irregular menstrual cycles, and increased risks of cardiometabolic conditions, underscoring the importance of proactive screening and intervention strategies.
Read More
Impact of primary care physicians on cervical cancer screening disparities
May 14th 2024A study highlights how having a primary care physician significantly increases the likelihood of cervical cancer screening among lesbian, gay, and bisexual cisgender women, addressing disparities exacerbated by systemic discrimination and healthcare access challenges.
Read More
Prenatal cannabis and nicotine use linked to adverse pregnancy outcomes
May 14th 2024A recent study highlights the heightened risks of maternal and neonatal morbidity and mortality associated with combined cannabis and nicotine use during pregnancy, urging further investigation into their impact on short- and long-term outcomes.
Read More
Echogenic Mass identified as key predictor for retained products of conception
May 13th 2024Discover how recent findings highlight the significance of echogenic masses in accurately diagnosing post-pregnancy complications, shedding light on effective management strategies and reducing the need for invasive interventions.
Read More